CAPROCK Group, Inc.
- SEC CIK
- 0001610769
- Latest filing
- Jul 27, 2026
ADMA holding history
Adma Biologics, Inc. in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADMA overviewAll 13F holders of ADMAFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −10,598−100.0% | Sold out | Holders |
| Q3 2024 | 10,598 | $211.9K | <0.1% | −3,505−24.9% | Reduced | Holders |
| Q2 2024 | 14,103 | $157.7K | <0.1% | +423+3.1% | Added | Holders |
| Q1 2024 | 13,680 | $90.3K | <0.1% | +1,452+11.9% | Added | Holders |
| Q4 2023 | 12,228 | $55.3K | <0.1% | −89−0.7% | Reduced | Holders |
| Q3 2023 | 12,317 | $44.1K | <0.1% | +2,056+20.0% | Added | Holders |
| Q2 2023 | 10,261 | $37.9K | <0.1% | +10,261 | New | Holders |